Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| BCAP-XHEALTH | DAOL-GIHEALTH | |
|---|---|---|
| Held by both | ||
| 2.03% | 4.28% | |
| 1.62% | 3.71% | |
| 1.37% | 3.51% | |
| 1.33% | 4.28% | |
| 1.32% | 4.79% | |
| 1.22% | 3.61% | |
| Only in BCAP-XHEALTH | ||
| 1.92% | N/A | |
| 1.87% | N/A | |
| 1.66% | N/A | |
| 1.21% | N/A | |
| Only in DAOL-GIHEALTH | ||
| N/A | 3.48% | |
| N/A | 2.99% | |
| N/A | 2.95% | |
| N/A | 2.88% | |
30 Dec 2025 → 28 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| BCAP-XHEALTH | +20.18% | 19.56% | 1.03 |
| DAOL-GIHEALTH | −1.74% | 18.54% | −0.09 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | BCAP-XHEALTH | DAOL-GIHEALTH |
|---|---|---|
Fund details | ||
| Fund size | 470 million | 75.01 million |
| Inception date | 14 May 2021 | 28 May 2020 |
| Master fund | กองทุนที่ลงทุนหลายกอง | Janus Henderson Horizon Biotechnology Fund |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 6 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 77.55% |
Minimum purchase and redemption | ||
| First purchase | 500 THB | 1 THB |
| Subsequent purchase | 500 THB | 1 THB |
| Redemption (amount) | No minimum | No minimum |
| Redemption (units) | No minimum | No minimum |
| Balance (amount) | No minimum | No minimum |
| Balance (units) | No minimum | 100 units |
Order cut-off and redemption payment | ||
| Buy before | 15:30 | 15:00 |
| Redeem before | 15:30 | 15:00 |
| Redemption paid | T+3 | T+4 |